ClinicalTrials.gov research-record snapshot for Miami, FL
Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 28 results; after an exact city/state check of listed facilities, 28 records were retained for Miami, Florida. It is not a clinic, enrollment, or local-availability directory.
Snapshot methodology and exact-location matching
City/state source filter
Miami, Florida
Exact-location inclusion rule
A listed facility city and state must match Miami, Florida.
Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.
Fixed query terms
semaglutide
tirzepatide
cagrilintide
retatrutide
tesamorelin
sermorelin
ipamorelin
bpc-157
thymosin alpha 1
pt-141
Included study statuses
RECRUITING
NOT_YET_RECRUITING
ACTIVE_NOT_RECRUITING
ENROLLING_BY_INVITATION
How to read this snapshot
Research-record limits
This is not a clinic, enrollment, local-service, or local-availability directory.
Why Peptides does not recommend sites, assess eligibility, or provide medical advice.
A listing or study-level status does not prove enrollment, eligibility, safety, effectiveness, or availability.
Each displayed registry status is a study-level overall status, not a facility enrollment status.
Links on this page lead only to the cited ClinicalTrials.gov source records and search pages.
Records are a fixed snapshot, not a complete or live catalog.
All retained records
Study-level status mix
The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.
RECRUITING
10 records
NOT_YET_RECRUITING
2 records
ACTIVE_NOT_RECRUITING
16 records
ENROLLING_BY_INVITATION
0 records
Records in this snapshot
Retained ClinicalTrials.gov NCT records
The retrieved source snapshot contains 28 exact-location records and 28 listed facilities. All 28 retained records are shown below.
Registry title: A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Registry title: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Registry title: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Research Associates of South Florida - Miami - Southwest 8th StreetMiami, Florida 33134
Gastro Health Research - MiamiMiami, Florida 33176
Registry title: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Research Associates of South Florida - Miami - Southwest 8th StreetMiami, Florida 33134
Gastro Health Research - MiamiMiami, Florida 33176
Registry title: Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Paramo HealthMiami, Florida 33175
IMIC Research a Rovia Clinical Research CompanyMiami, Florida 33176
Registry title: A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Study-level overall status
NOT_YET_RECRUITING
Record update date
Exact-matched listed facility/location
PharmaDev Clinical Research Institute LLCMiami, Florida 33176
Registry title: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Registry title: A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Registry title: Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
New Age Medical Research CorporationMiami, Florida 33186
Registry title: Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
International Research AssociatesMiami, Florida 33183
Registry title: A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
Registry title: A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Registry title: Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
Study-level overall status
NOT_YET_RECRUITING
Record update date
Exact-matched listed facility/location
Clever Medical Research - PCRS NetworkMiami, Florida 33126
Source retrieval and snapshot limits
Source-query results versus exact-location records
At retrieval, the fixed ClinicalTrials.gov source query returned 28 results. After an exact city/state check of listed facilities, 28 records were retained for Miami, Florida, across 28 listed facilities. All 28 retained records are shown on this page.
Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.
Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.